The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus
Clinical trial NCT03240575 · COMPLETED
Trial details
- NCT number
- NCT03240575
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2019-04-08
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.